Quaker Chemical (NYSE:KWR) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsDavid Begleiter - Managing Director of Equity ResearchJeffrey Schnell - Head of Investor RelationsJonathan Tanwanteng - Managing Director of Equity ResearchJoseph Berquist - President and CEOMichael Harrison - Managing Director of Equity ResearchTom Coler - EVP and CFOConference Call ParticipantsArun Viswanathan - Senior Equity Research AnalystLaurence Alexander - Equity Research AnalystOperatorReminder, this ...

Financial Data and Key Metrics Changes - Full year 2025 net sales reached $2.3 billion, an increase of 4.5% from 2024, with growth driven by pricing (3%), acquisitions (1%), and foreign exchange (1%), partially offset by a 1% decline in volume due to weaker housing starts [5][12] - Consolidated net sales for Q4 2025 increased 4.2% year-over-year to $539.3 million, with North America segment net sales up 3% to $416.9 million [17] - Consolidated gross profit increased 3.4% to $235.1 million, resulting in a gross margin of 43.6%, down 30 basis points from Q4 2024 [18] - Adjusted EBITDA for Q4 was $104.7 million, a decrease of 0.9%, resulting in a margin of 19.8% [22] Business Line Data and Key Metrics Changes - North American volumes were down year-over-year, pressured by lower housing starts, with the OEM business delivering strong growth with volume up double digits [7][8] - The component manufacturing business grew with volumes up in the low single digits, driven by new customer acquisitions and expanded capabilities [8] - The commercial business saw flat volumes year-over-year, while the residential business volume declined modestly due to challenging market conditions [10][11] Market Data and Key Metrics Changes - In Europe, full year net sales totaled $499.6 million, up 4.3% year-over-year, with volumes slightly higher compared to 2024 [12] - The North American market faced a decline in housing starts, with expectations of a 2-3% decrease for the year [29][74] - The commercial market is anticipated to be flat to up 1-2% in 2026, while national retail is expected to remain flat to low single digits [40] Company Strategy and Development Direction - The company aims to maintain above-market volume growth relative to U.S. housing starts, with a focus on innovation, customer service, and operational excellence [14][15] - Strategic priorities include expanding digital capabilities and enhancing customer relationships through software and services [9][81] - The company is targeting a 20% operating income margin and plans to return at least 35% of free cash flow to shareholders [25][27] Management's Comments on Operating Environment and Future Outlook - Management expressed a conservative view on the housing market for 2026, expecting flat conditions and potential risks from declining housing starts [29][32] - The company remains optimistic about its ability to outperform the market, citing historical performance and ongoing strategic initiatives [30][31] - Management highlighted the importance of maintaining high customer satisfaction and operational efficiency as key drivers for future success [14][26] Other Important Information - The company achieved a recordable incident rate of less than 1.0 for safety, reflecting its commitment to employee safety [4] - Total operating expenses for 2025 increased by 6.5%, primarily due to variable incentive costs and personnel costs [20] - The company has authorized a new share repurchase program for 2026, reflecting confidence in long-term prospects [24] Q&A Session Summary Question: Can you talk about the upside and downside cases to your outlook for flat North American housing starts? - Management noted a conservative view on the market, expecting flat conditions and potential risks from declining housing starts [29] Question: Can you add some more color to the outlook for growth in Europe? - Management expressed satisfaction with progress in Europe, expecting low single-digit growth and focusing on profitability [33][35] Question: What are the expectations for the commercial side or R&R in the U.S.? - Management anticipates flat to low single-digit growth in the commercial market, with ambitions to outperform housing starts [40][41] Question: Can you elaborate on the gross margin outlook for 2026? - Management expects slightly lower gross margins due to tariff costs and pricing dynamics, with a focus on maintaining operating income margins [42][45] Question: How do you view the impact of steel prices on gross margins? - Management is comfortable with current steel prices and does not expect significant impacts on gross margins for 2026 [60][61] Question: How are customer expectations aligning with market forecasts for 2026? - Management indicated that customer expectations are merging with third-party forecasts, but they remain cautious until a market pickup is observed [62][64]

Financial Data and Key Metrics Changes - The company reported net sales of approximately $1.5 billion for Q4 2025, a 4% increase from the prior year, driven by higher raw material costs and favorable foreign currency translation [17] - Adjusted EBIT for Q4 was $150.6 million, relatively flat compared to the prior year, while adjusted EPS decreased by $0.18 to $0.67 due to higher interest expense and tax rates [18] - Adjusted EBIT and EBITDA margins expanded by 150 basis points, positioning the company for accelerated growth in the coming years [12] Business Line Data and Key Metrics Changes - The Dispensing and Specialty Closures segment saw a 1% increase in sales for Q4, primarily due to foreign currency translation, while adjusted EBIT remained comparable to the prior year [19] - The Metal Containers segment experienced an 11% increase in sales, attributed to higher raw material costs and a 4% growth in volumes, particularly in pet food products [20] - Custom Containers sales decreased by 8% compared to the prior year due to lower-margin business exits, but adjusted EBIT remained consistent with prior year levels [21] Market Data and Key Metrics Changes - The company anticipates organic volume growth in Dispensing and Specialty Closures to be in the low to mid-single-digit range for 2026, driven by growth in dispensing products [13] - Metal Containers volumes are expected to grow by a low single-digit percentage, primarily due to continued growth in pet food [13] - Custom Containers volumes are expected to be flat, with some impact from customer destocking in Q1 2026 [14] Company Strategy and Development Direction - The company successfully integrated the Weener acquisition and achieved full run rate synergies, positioning itself for organic growth exceeding that of peers [9] - Strategic initiatives are focused on operational excellence, market-leading innovation, and providing total value solutions to customers [9] - The company is optimistic about growth opportunities in both organic and inorganic avenues as it enters 2026 [12] Management's Comments on Operating Environment and Future Outlook - Management noted that 2025 was a challenging year due to evolving consumer spending trends, but the company adapted and strengthened its processes for future agility [10] - The outlook for 2026 includes expectations for significant value creation for shareholders, with a focus on meeting unique customer needs [15] - Management has taken a broader view of risks and uncertainties in the market, incorporating these into their guidance for 2026 [61] Other Important Information - The company returned approximately $160 million in capital to shareholders and returned to its target leverage range following the Weener acquisition [8] - The company expects free cash flow of approximately $450 million for 2026, with operating earnings growth offset by higher cash interest and tax [24] Q&A Session Summary Question: Details on first quarter outlook for Dispensing and Specialty Closures - Management indicated low- to mid-single-digit volumes for the first quarter, with challenges from low-cost inventory impacting EBIT [29] Question: Changes in order patterns and operations in Dispensing and Specialty Closures - Management acknowledged that the business has evolved significantly, requiring a broader view of macro influences affecting customer demand [31][32] Question: Key volume and margin considerations at the low end of guidance - Management pointed to broader market conditions as a potential factor influencing demand and margins [35] Question: Performance of hot fill beverage and destocking impacts - Management confirmed that destocking activity in personal care and home care products is complete, with expectations for comparable volumes in food and beverage [39][52] Question: Wins from Weener acquisition and growth expectations - Management highlighted successful integration and new business awards, particularly in North America, leveraging Weener's technology [56][71] Question: Impact of steel and aluminum tariffs on customer behavior - Management believes the market has absorbed the tariff costs, with ongoing discussions about pricing strategies for 2026 [82] Question: Growth potential in healthcare and acquisitions - Management expressed confidence in doubling the size of the healthcare business over the next few years, with organic growth being a primary focus [66][85]

Financial Data and Key Metrics Changes - Net sales for the quarter decreased by 12.5% year-over-year, primarily due to lower demand in the Asia segment and pricing pressure in Brazil [9] - Consolidated gross profit was $3.6 million with a gross margin of 3%, compared to a gross profit of $500,000 and a gross margin of 0.4% in the same quarter last year [9] - SG&A expenses were $9.7 million, reflecting a 25% improvement from the prior year [9] - Adjusted EBITDA loss improved by $5.1 million compared to the previous year, now at a loss of $0.7 million [9] Business Line Data and Key Metrics Changes - In the Americas, net sales decreased by 7.1% due to a lower portion of fiber sales and tariff uncertainty, but gross profit increased by $6.1 million due to cost-saving initiatives [10] - Brazil segment saw declines in net sales and gross profit due to pricing pressures, but demand and growth opportunities remain strong [11] - Asia segment experienced a 27% decline in net sales and a 10% decline in gross profit, although gross margin improved by 260 basis points year-over-year [12] Market Data and Key Metrics Changes - Demand in Central America has picked up, presenting a near-shoring opportunity for retailers and brands in North America [5] - Holiday sales for apparel were solid, with a 4% increase, indicating a positive trend in customer orders [4] - Tariff complexities have created uncertainty, but recent agreements in Central America may improve conditions for future sales [29] Company Strategy and Development Direction - The company is focused on returning to long-term growth and profitability through cost structure realignment and operational improvements [17][18] - Key areas of focus include improving the operating model, investing in brand strength, fostering innovation, and converting operational progress into financial momentum [18][19] - The company has executed strategic initiatives to streamline operations and reduce costs, including the sale of the Madison facility and headcount reductions [20][21] Management's Comments on Operating Environment and Future Outlook - Management is cautiously optimistic about improved order trends and customer engagement, particularly in the U.S. and Central America [4][8] - The company anticipates realizing full benefits from cost reduction initiatives and improved working capital efficiency in the upcoming quarters [14][28] - There is an expectation for revenue improvement as clarity on the global trade environment increases [28] Other Important Information - Year-to-date free cash flow reached $13.3 million, a significant increase compared to the previous year [13] - Net debt was reduced to $75 million, reflecting improvements in the balance sheet and capital structure [14] - The company is prioritizing disciplined inventory builds to support higher sales activity in the future [15] Q&A Session Summary Question: Demand pickup across segments - Management noted that demand is improving across all segments, with Brazil showing positive momentum post-holiday and Central America benefiting from tariff agreements [36][37] Question: Update on Beyond Apparel initiatives - Beyond Apparel initiatives are performing well, particularly in packaging and carpet sectors, with expectations for growth in military and tactical areas [38][39] Question: Pricing dynamics in segments - Pricing pressures in Brazil are easing, while slight price increases are observed in Asia due to supply chain dynamics [44][45] Question: Break-even revenue mix - The break-even revenue point is estimated at $575 million, with expectations for mid- to high-300s gross margins in the Americas and contributions from other segments [48]

Financial Data and Key Metrics Changes - Full year sales for 2025 were $2.1 billion, consistent with the previous year [4] - Operating income for the year was $287 million, with earnings per share at $5.52 [5] - Fourth quarter sales were $520 million, reflecting a slight increase from the prior year, driven by a 2% growth in engineered solutions [9] - Operating margin for the full year was 13.9%, down from 14.9% in the prior year, primarily due to lower volume [11] Business Line Data and Key Metrics Changes - Consumer and specialties segment sales for the fourth quarter were $274 million, with household and personal care products seeing a 2% sequential increase [12] - Engineered solutions segment sales grew 2% year-over-year to $245 million, with high temperature technologies sales at $178 million, up 1% [17] - Full year sales in consumer and specialties were $1.1 billion, with household and personal care sales down 3% overall but improved by 5% in the second half [13] Market Data and Key Metrics Changes - The company faced challenges in key end markets, with many remaining flat or weakening throughout 2025 [5] - Sales to paper and packaging customers increased by 3% in the second half of the year compared to the first half, indicating a recovery [16] - The residential construction market showed softness, impacting sales in specialty additives [14] Company Strategy and Development Direction - The company is focused on organic growth strategies, including expanding into higher growth consumer-oriented markets and introducing innovative, higher margin products [5] - Investments were made in various facilities to support growth, including upgrades to pet litter facilities and expansion of natural oil purification operations [6] - The company aims to maintain a balanced approach to capital deployment, returning $73 million to shareholders while supporting growth initiatives [19] Management's Comments on Operating Environment and Future Outlook - Management noted that 2025 was a challenging year due to geopolitical uncertainty and softer market demand, but expressed confidence in the growth investments made [3][4] - For 2026, the company expects stable market conditions with potential for mid-single-digit growth across segments [23] - Management highlighted the importance of volume growth in driving margin improvements and expressed optimism about new business opportunities in various product lines [37][72] Other Important Information - The company achieved a world-class safety performance in 2025, marking the best in its history [4] - Full-year cash from operations was $194 million, with free cash flow at $87 million [19] - The balance sheet remains strong, with over $700 million in liquidity and a net leverage ratio of 1.7x EBITDA [20] Q&A Session Summary Question: Consumer and specialties segment margin performance - Management indicated that the fourth quarter margin was in line with expectations, impacted by lower residential construction demand and fixed cost absorption issues [36] Question: Paper PCC business growth and market conditions - Management noted that Asia presents significant growth opportunities, with ongoing consolidation in the paper market and new technologies driving demand [40][41] Question: Capital deployment strategy for 2026 - The company plans to maintain a balanced approach, returning 50% of free cash flow to shareholders while keeping some for inorganic growth opportunities [48][49] Question: Visibility into fabric care and pet care markets - Management expressed confidence in volume growth for fabric care and highlighted strong expectations for pet litter growth due to new business secured [60][65]

Financial Data and Key Metrics Changes - The fourth quarter results were significantly below expectations due to operational issues and a sharp decline in chlorine pipeline demand [5][7] - Operating cash flow for the quarter was approximately $321 million, maintaining net debt flat compared to year-end 2024 [18][19] - The company achieved $44 million in structural cost savings in 2025 and expects an additional $100 million to $120 million in 2026 [14][22] Business Line Data and Key Metrics Changes - Chloralkali products faced pressure from merchant chlorine demand and increased competition from subsidized Asian producers [7][8] - The Epoxy business saw sequential growth due to improved product mix and margins, although it remains in a low profitability state [10][62] - The Winchester business adjusted its operating model to reflect lower commercial ammunition demand, with a focus on military sales growth [12][38] Market Data and Key Metrics Changes - Global caustic soda demand remains healthy, driven by sectors like alumina and water treatment, with expectations of tighter supply due to low inventories and planned industry turnarounds [8][9] - The company noted a significant increase in exports of chlorine derivatives from China, impacting U.S. customers [7][8] - The PVC market is currently under pressure due to excess capacity, particularly in China, but the company remains optimistic about long-term demand recovery [41][43] Company Strategy and Development Direction - The company is focused on a value-first commercial approach and has entered a long-term EDC supply agreement with Braskem to enhance value [5][6] - Olin is expanding its infrastructure in Brazil to grow caustic sales and has positioned itself as a key integrated supplier of Epoxy in Europe [6][10] - The Beyond250 structural cost reduction program aims to identify inefficiencies and improve operational performance across all business lines [14][15] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing challenges in the chloralkali market and expects continued headwinds from power and raw material costs in the first quarter of 2026 [8][9] - The company anticipates modest improvements in Winchester results due to higher commercial ammunition volume and pricing, despite rising costs [12][38] - Management expressed confidence in the company's preparedness for future demand recovery and emphasized the importance of maintaining cost discipline [33][39] Other Important Information - The company expects to maintain its quarterly dividend payments and is targeting approximately $200 million in capital spending for 2026 [21][22] - A significant stranded cost of approximately $70 million is anticipated due to the closure of Dow's Freeport propylene oxide plant, which the company is working to offset through cost reductions [9][16][55] Q&A Session Summary Question: Chlorine pipeline demand decline and recovery expectations - Management noted that the decline in chlorine pipeline demand was primarily due to destocking and expects a recovery in demand to begin in the warmer months of Q2 2026 [26][28] Question: Impact of competitor capacity closures - Management indicated that capacity rationalization is occurring globally and expects operating rates to improve as a result [31][32] Question: Military demand trends at Winchester - Significant growth in military revenue was reported, with expectations for continued growth in 2026, particularly in international military sales [36][38] Question: Pricing and margin improvement visibility for Winchester - Management stated that while cost reductions have been implemented, further pricing increases are necessary to recover margins, which are currently below satisfactory levels [80][81]

Financial Data and Key Metrics Changes - The fourth quarter results were significantly below expectations due to operational issues and a decline in chlorine pipeline demand [4][6] - Operating cash flow for the quarter was approximately $321 million, maintaining net debt flat compared to year-end 2024 [6][18] - The company achieved $248 million in cash from proactive working capital reductions throughout 2025 [18] Business Line Data and Key Metrics Changes - Chloralkali products faced pressure from merchant chlorine demand and increased competition from subsidized Asian producers [6][8] - The Epoxy business saw sequential growth due to improved product mix and margins, although it was partially offset by higher turnaround costs [9][61] - The Winchester business adjusted its operating model to reflect lower commercial ammunition demand, resulting in aggressive inventory reductions [10][11] Market Data and Key Metrics Changes - Global caustic soda demand remains healthy, driven by sectors like alumina and water treatment, despite lower volumes expected in the first quarter [7][30] - The company noted a significant increase in exports of chlorine derivatives from China, impacting U.S. customers [6][8] - The military ammunition segment saw growth, particularly in international markets, while commercial demand remained subdued [35][36] Company Strategy and Development Direction - The company is focused on a value-first commercial approach and has entered a long-term EDC supply agreement with Braskem to enhance value [4][5] - Olin is committed to its Beyond250 structural cost reduction program, aiming for $100 million to $120 million in additional savings in 2026 [14][17] - The company is exploring potential expansions into PVC through joint ventures and partnerships, while remaining cautious about market conditions [41][42] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing challenges in the chloralkali market and expects a slow recovery in chlorine demand until warmer months [28][33] - The company anticipates continued headwinds from rising costs in natural gas and power, alongside stranded costs from Dow's plant closure [8][19] - There is optimism regarding caustic pricing and expected improvements in the Epoxy business profitability in 2026 [9][61] Other Important Information - The company ended 2025 with very low inventories, which is expected to tighten caustic supply as seasonal demand returns [7][8] - The closure of the Guarujá, Brazil, Epoxy plant is expected to deliver $10 million in annual structural savings [9][16] - The company is committed to maintaining its dividend payments while managing capital expenditures effectively [20][21] Q&A Session Summary Question: Chlorine pipeline demand decline and recovery expectations - Management noted a sharp decline in chlorine pipeline demand in Q4 due to destocking and does not expect a large bounce back until warmer months [26][28] Question: Impact of competitor capacity closures - Management indicated that capacity rationalization is occurring globally, which should improve supply-demand balances as demand recovers [31][32] Question: Military demand trends at Winchester - Significant growth in military revenue was observed, particularly in international markets, while commercial demand remains at pre-COVID levels [35][36] Question: PVC tolling arrangements and future participation - The company is exploring options for expanding into PVC, including joint ventures, while remaining optimistic about long-term market conditions [41][42] Question: Q1 guidance and cost impacts - Management discussed various headwinds, including increased turnaround spending and higher energy costs, impacting Q1 performance [45][49] Question: Clarification on stranded costs - Management explained that the $70 million stranded costs are related to the closure of Dow's plant and are being managed through the Beyond250 program [53][54] Question: Volume and EBITDA benefits from Braskem EDC arrangements - Management highlighted the partnership with Braskem as beneficial for both parties, particularly in enhancing caustic sales infrastructure in Brazil [71][72]

Core Viewpoint - United Parcel Service (UPS) is facing challenges reflected in a projected earnings per share (EPS) decline of 19.3% and a revenue decrease of 5.1% for the upcoming quarter, yet it remains a significant player in the logistics industry due to strategic initiatives and operational efficiency [1][2][3]. Financial Performance - The anticipated EPS for UPS is $2.22, marking a 19.3% decrease from the previous year, attributed to reduced volumes from Amazon and weak shipment trends [2][6]. - Revenue is projected to be approximately $24 billion, which represents a 5.1% decline compared to the same quarter last year [3][6]. - The company's price-to-earnings (P/E) ratio stands at 16.52x, with a target price range between $113 and $149, indicating an attractive valuation [3]. Operational Efficiency - UPS's price-to-sales ratio is 1.03, and its enterprise value to sales ratio is 1.28, reflecting the company's valuation relative to its sales [4]. - The enterprise value to operating cash flow ratio is 13.48, showcasing UPS's operational efficiency in generating cash flow [4]. Debt and Liquidity - The debt-to-equity ratio of UPS is 1.85, indicating a significant level of debt compared to equity, but the company maintains a current ratio of 1.30, suggesting good liquidity to cover short-term liabilities [5].

Core Viewpoint - Pfizer has released a conservative earnings guidance for 2026, planning to invest in pipeline assets to counteract declining sales from COVID-related products and shrinking revenue from older drugs [3][5][10]. Financial Projections - The company expects adjusted earnings per share for 2026 to be in the range of $2.80 to $3.00, slightly below analysts' expectations of $3.05 [11]. - Pfizer anticipates revenue for 2026 to reach between $59.5 billion and $62.5 billion, consistent with the 2025 revenue guidance of $62 billion [4][11]. Sales Decline Factors - The revenue outlook is impacted by a projected decline of approximately $1.5 billion in sales from COVID vaccines and the oral antiviral drug Paxlovid, bringing their total sales down to $5 billion [4][11]. - Additionally, the loss of market exclusivity for several products is expected to contribute to another $1.5 billion decline in sales [4][11]. Patent Expiration and Market Competition - Pfizer's CFO indicated that the peak of patent expirations is expected between 2026 and 2028, potentially affecting revenues by $17 billion due to the expiration of patents and regulatory exclusivities [6][11]. - Key products, including the anticoagulant drug Eliquis, will face pricing pressures due to new government regulations [12]. Cost Management and Restructuring - The company has exceeded its cost-saving targets for 2025 and aims to achieve over $7 billion in cost reductions by 2027, with most savings expected to materialize in the coming year [13]. - Analysts noted that the earnings outlook aligns with market expectations, and the cost restructuring plan may help mitigate pressures from declining COVID-related business [12][13]. Regulatory Environment and Pricing Agreements - Pfizer has entered a significant drug pricing agreement with the Trump administration, committing to provide existing drugs at the lowest prices available in other developed countries [14]. - The company plans to increase discounts for its Medicare business, which has been factored into the 2026 earnings guidance, considering the impact of price compression and margin contraction [14].

Investment Rating - The industry rating is "Recommended" [6] Core Insights - In Q3 2025, Newmont's attributable gold production decreased by 4.1% quarter-on-quarter to 1.42 million ounces (approximately 44.2 tons), and sales decreased by 4.0% to 1.308 million ounces (approximately 40.68 tons) [1] - The average realized gold price in Q3 2025 was $3,539 per ounce, reflecting a quarter-on-quarter increase of 6.6% and a year-on-year increase of 40.5% [2] - Adjusted net income for Q3 2025 was $1.883 billion, representing a quarter-on-quarter increase of 18.1% and a year-on-year increase of 101.2% [7] Production and Sales - Newmont's total gold production in Q3 2025 was impacted by lower grades at Peñasquito and Lihir mines, as well as planned shutdowns, with a notable decrease in production from the Ahafo South mine [1] - The increase in production from Brucejack, Cerro Negro, and Yanacocha mines partially offset the declines [1] Financial Performance - Total revenue for Q3 2025 was $5.524 billion, a year-on-year increase of 19.96% and a quarter-on-quarter increase of 3.9% [4] - Costs and expenses for Q3 2025 were $2.948 billion, a year-on-year decrease of 15.2% but a quarter-on-quarter increase of 31% [4] - The company reported a net income attributable to Newmont stockholders of $1.832 billion for Q3 2025 [5] Cost Metrics - The cash cost per ounce of gold sold (CAS) excluding by-product revenue was $1,185, a decrease of 2.5% quarter-on-quarter and 1.8% year-on-year [2] - The all-in sustaining cost (AISC) including by-product revenue was $1,303 per ounce, a decrease of 5.2% quarter-on-quarter and 15.5% year-on-year [3] Future Guidance - Newmont expects its attributable gold production for 2026 to remain within the guidance range set for 2025, with a focus on cost-saving initiatives and production efficiency improvements [14] - The company has adjusted its capital expenditure guidance, deferring some spending to the following year [13] Asset Divestiture - Newmont has completed the divestiture of all non-core assets, including the sale of its remaining interest in the Coffee project, which is expected to yield up to $150 million [15]